K-numberK243147
Device nameLGO-Surgical Laser Fibers
ApplicantLight Guide Optics International , Ltd.
Product codeGEX
Device classClass II
Decision dateDec 21, 2024
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

LGO-Surgical Laser Fibers are single-use or reusable (up to 10 uses) laser fiber delivery devices intended to transmit laser radiation to target tissue during surgical procedures. They are used with cleared surgical lasers operating at wavelengths between 500 nm and 2200 nm, equipped with SMA 905 connectors, in general surgery, plastic surgery, and dermatology applications.

Technological characteristics

The device features a core diameter of 145–1000 µm (slightly smaller than the predicate's 200–1000 µm range), construction materials including silica quartz glass, hard clad, silicone, polyimide, nylon, and ETFE, and operates across 500–2200 nm wavelengths matching the predicate. Both support single-use and reusable (10×) configurations with ethylene oxide sterilization and SMA 905 connectors, though the subject device does not support SMA 906 compatibility.

Test standards cited

ISO 10933 series (biocompatibility testing including cytotoxicity, skin sensitization, systemic toxicity, and irritation), ISO 11135:2014 (ethylene oxide sterilization validation), ISO 17665-1:2006 (moist heat sterilization), ISO 11607 series (packaging and sterile barrier validation), plus functional tests including beam profile, light transmission, connector pull/torque tests, and accelerated aging studies.

Substantial equivalence argument

The LGO-Surgical Laser Fibers are substantially equivalent because they share the same product code (GEX), indications for use (laser radiation delivery with 500–2200 nm wavelengths via SMA 905 connectors), operating wavelength range, sterilization method, and usage modes (single or 10× reusable) as the predicate device. Minor differences in core diameter range and construction materials (absence of acrylate and SMA 906 support) do not raise new safety or effectiveness concerns, as demonstrated by biocompatibility and functional performance testing meeting all acceptance criteria.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →